An open-label study of levopromazine (methotrimeprazine) as an add-on therapy in fibromyalgia management

Clinical and Experimental Rheumatology

Volumn 27, Issue 5 SUPPL. 56, 2009, Pages

  Rico Villademoros, F ^a   Hidalgo, J ^a   Morillas Arques, P ^a   Vilchez, J S ^a   Delgado Rodriguez, A ^a   Calandre, E P ^a  

^a UNIVERSITY OF GRANADA   (Spain)

Author keywords

Analgesic; Antipsychotic; Chronic pain; Fibromyalgia; Levopromazine; Methotrimeprazine; Neuroleptic; Sleep

Indexed keywords

ANALGESIC AGENT; LEVOMEPROMAZINE;

ADULT; ANALYSIS OF VARIANCE; ARTICLE; DRUG EFFECT; FEMALE; FIBROMYALGIA; HUMAN; INTENTION TO TREAT ANALYSIS; MALE; MIDDLE AGED; PAIN ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRE; SLEEP; TREATMENT OUTCOME;

ADULT; ANALGESICS, NON-NARCOTIC; ANALYSIS OF VARIANCE; FEMALE; FIBROMYALGIA; HUMANS; INTENTION TO TREAT ANALYSIS; MALE; METHOTRIMEPRAZINE; MIDDLE AGED; PAIN MEASUREMENT; PATIENT SATISFACTION; QUALITY OF LIFE; QUESTIONNAIRES; SLEEP; TREATMENT OUTCOME;

EID: 77951887070     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. WOLFE F, SMYTHE HA, YUNUS MB et al : The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Comrmttee Arthrith Rheum 1990; 33: 160-72.
2. BENNETT RM, SCHEIN J, KOSINSKI MR el al. Impact of fibromyalgia pain on healthrelated quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum 2005; 53: 519-27.
3. BURCKHARDT CS, CLARK SR, BENNETT RM: Fibromyalgia and quality of life: a Comparative analysis. J Rheumatol 1993;20: 475-9.
4. WOLFE F, ANDERSON J. HARKNESS D et al. Work and disability status of persons with fibromyalgia . J Rheumatol 1997; 24: 1171-8.
5. WOLFE F, ANDERSON J, HARKNESS D et al A prospective, longitudinal, multicenter study of service utilization and costs in fibromyalgia. Arthritis Rheum. 1997; 40: 1560-70.
6. ABELES M, SOLITAR BM PILLINGER MH ABELES AM: Update on fibromyalgia therapy. Am J Med 2008; 121: 555-561
7. MUNGUÍA-IZQUIERDO D, LEGAZ-ARRESE A: Exercise in warm water decreases pair and improves congnitive function in middleiged women eith fibromyalgia. Clin Exp rheumatol 2007; 25: 823-30.
8. ARNOLD LM: Biology and therapy of fibromyalgia. New therapies in fibromyalgia. Arthritis Res 2006; 8: 212.
9. MAIZELS M, MCCARBERG B: Antidepressants and antiepileptic drugs for chronic noncancer pain. Am Earn Physician 2005; 71: 483-90.
10. PRIDMORE S, ROSA MA: Fibromyalgia for the psychiatrist. Ger J Psychiatry 2001;4:1-8.
11. PATT RB, PROPER G, REDDY S: The neuroleptics as adjuvant analgesics. J Pain Symptom Manage 1994;9: 446-53.
12. FISHBAIN DA, CUTLER RB, LEWIS J et al. Do the second-generation "atypical neuroleptics" have analgesic properties?. A structured evidence-based review. Pain Med 2004; 5: 359-65.
13. PRIDMORE S, SAMILOWITZ H, OBEROI G: Will the atypical antipsychotics be analgesics? Australas Psychiatry 2003; 11: 59-61.
14. FREEDENFELD RN, MURRAY M, FUCHS PN, KISER RS: Decreased pain and improved quality of life in fibromyalgia patients treated with olanzapine, an atypical neuroleptic. Pain Practice 2006; 6: 112-8.
15. RICO-VILLADEMOROS F, HIDALGO J, DOMINGUEZ I et al.: Atypical antipsychotics in the treatment of fibromyalgia: a case series with olanzapine. Prog Neuropsychopharmacol Biol Psychiatry 2005; 29: 161-164
16. CALANDRE E.P, HIDALGO J. RICO-VILLA-DEMOROS F: Use of ziprasidone in patients with fibromyalgia: a case series. Rheumatol Int 2007; 27: 473-6.
17. SHEMO M, SHEMO JPD, ANDERSON M: Beneficial effects of quetiapine treatment in patients with fibromyalgia, (abstract) J Neuropsychiatry Clin Neurosci 2003; 15: 282.
18. HIDALGO J. RICO-VILLADEMOROS F. CALANDRE EP: An open-label study of quetiapine in the treatment of fibromyalgia. Prog Neuropsychopharmacol Biol Psychiatry 2007:31:71-7.
19. CALANDre EP, MORILLAS-ARQUES P, RQ DRIGUEZ-LQPEZ CM et al: Pregabalin augmentation of quetiapine therapy in the treatment of fibromyalgia: an open-label, prospective trial. Pharmacopsychiatry 2007; 40: 68-71.
20. Nozinan® Product Monograph 2007. Sanofi-Aventis Canada Inc. Laval, Québec (Canada). Date of Revision: May 18, ,2007 Accessed November 7th, 2007 URL: www.sanofi-aventis.ca/products/en/nozinan.pdf
21. BENNETT R: The Fibromyalgia Impact Questionnaire (FIQ): a review of its development, current version, operating characteristics and uses. Clin Exp Rheumatol 2005; 23(5 Suppl 39): 154-62.
22. BURCKHARDT CS, CLARK SR, BENNETT RM: 1991. The fibromyalgia impact questionnaire: development and validation. J Rheumatol 18: 728-33.
23. RIVERA J, GONZÁLEZ T: The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004; 22: 554-60.
24. GUY W: ECDEU Assessment Manual for Psychopharmacology -Revised (DHEW Publ No ADM 76-338). Rockville, MD, U.S. Department of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, NIMH. Psychopharmacology Research Branch, Division of Extramural Research Programs, 1976,218-222
25. BECK AT, WARD CH, MENDELSON M, ERBAUGH J: An inventory for measuring depression. Arch Gen Psychiatry 1961; 4: 561-71.
26. VÁZQUEZ C, SANZ J: Fiabilidad y valores normativos de la versión espanola del Inventario para la Depresión de Beck de 1978. Clínica y Salud 1997; 8: 403-22.
27. SPIELBERGER CD: State-Trait Anxiety Inventory: A comprehensive bibliography. Consultant Psychologists Press: 1984, Palo Alto, CA.
28. a edición). Publicaciones de Psicología Aplicada. Serie menor número 124 TFA Edicones SA 2002, Madrid.
29. BUYSSE DJ, REYNOLDS CF 3RD, MONK TH et al: The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res 1989; 28: 193-213.
30. ROYUELA A, MACÍAS JA: Propiedades clinimétricas de la versión castellana del cuestionario de Pittsburg. Vigilia-Sueño 1997; 9: 81-94.
31. INSTITUT MUNICIPAL D'INVESTIOACÍO MÈDICA: BiblioPRO. Ficha técnica del instrumento: SF-12. Accesed January 7th, 2006. URL: http://iryss.imim.es/iryss/new-ficha.asp?id=243.
32. WARE JR. JE, KOSINSKI M, KELLER S: A 12-item Short-Form Health Survey. Med Care 1996;34:220-33.
33. KAZIS LE, ANDERSON JJ, MEENAN RF: Effect sizes for interpreting changes in health statu. Med Care 1989; 27:178-89.
34. VILAGUT G, FERRER M, RAJMIL L et al : El Cuestionario de Salud SF-36 español: una década de experiencia y nuevos desarrollos. Gac Sanit 2005; 19: 135-50.
35. MCGEE JL, ALEXANDER MR: Phenothiazine analgesia--fact or fantasy? Am J Hosp Pharm 1979;36:633-40.
36. LASAGNA L, DEKORNFELD T.I: Methotrimeprazine: a new phenothiazine derivative with analgesic properties. JAMA 1961; 178: 887-90.
37. MOLDOFSKY HK: Disordered sleep in fibromyalgia and related myofascial facial pain conditions. Dent Clin North Am 2001; 45: 701-13
38. NICASSIO PM, MOXHAM EG, SCHUMAN CE, GEVIRTZ RN: The contribution of pain, reported sleep quality, and depressive symptoms to fatigue in fibromyalgia. Pain 2002; 100: 271-9.
39. SMITH MT, HAYTHORNTHWAITE JA: How do sleep disturbance and chronic pain interrelate? Insights from the longitudinal and cognitive-behavioral clinical trials literature. Sleep Med Rev 2004; 8; 119-32.
40. AǦARGÜN MY, TEKEOǦLU I, GÜNEŞ A et al Sleep quality and pain threshold in patients with fibromyalgia. Compr Psychiatry. 1999; 40: 226-8.
41. ZELMAN DC, BRANDENBURG NA, GORE M: Sleep impairment in patients with painful diabetic peripheral neuropathy. Clin J Pain 2006; 22: 681-5.
42. MANOCCHIA M, KELLER S, WARE JE: Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual Life Res 2001; 10: 331-45.
43. DREWES AM, ANDREASEN A, JENNUM P, NIELSEN KD: Zopiclone in the treatment of sleep abnormalities in fibromyalgia. Scand J Rheumatol 1991;20; 288-93.
44. GRÖNBLAD M, NYKÄNEN J, KONTTINEN Y et al: Effect of zopiclone on sleep quality, morning stiffness, widespread tenderness and pain and general discomfort in primary fibromyalgia patients. A double-blind randomized trial. Clin Rheumatol 1993; 12: 186-91.
45. MOLDOFSKY H, LUE FA, MOUSLY C et al : The effect of Zolpidem in patients with fibromyalgia: a dose ranging, double blind, placebo controlled, modified crossover study. J Rheumatol 1996; 23: 529-33.
46. BRANCO JC, MARTINI A, PALVA T: Treatment of sleep abnormalities and clinical complaints in fibromyalgia with trazodone (abstract). Arthritis Rheum 1996; 39: 591.
47. EDINGER JD, WOHLGEMUTH WK, KRYSTAL AD, RICE JR: Behavioral insomnia therapy for fibromyalgia patients: a randomized clinical trial. Arch Intern Med 2005; 165; 2527-35.
48. COHRS S, RODENBECK A, GUAN Z et al.: Sleep-promoting properties of quetiapine in healthy subjects. Psychopharmacology (Berlin) 2004; 174:421-9.